The application of artificial intelligence(AI)in personalized diabetes treatment provides a better solution to ease the tension of medical resources in China,improve the efficiency of diagnosis and treatment of diabetes,and enable comprehensive remote management.Currently,developments of diabetes self-management system,diabetes and complications intelligent prediction and early screening system,and artificial pancreas closed-loop system have significantly improved the accuracy and efficiency of treatment,optimized patients'self-management ability,and promoted the innovation of medical practice.However,the development of AI in this field has also caused a range of ethical challenges,such as data privacy and security,algorithmic bias and fairness,informed consent and data usage transparency,and the responsibility gap in medical decision-making.This paper attempts to propose feasible governance strategies aimed at harmonizing technical and ethical standards to achieve the sustainable development of AI in personalized diabetes treatment.
维普
万方数据
